Suppr超能文献

新合成的表面活性蛋白 B 向肺泡 II 型细胞板层小体的转运。

Trafficking of newly synthesized surfactant protein B to the lamellar body in alveolar type II cells.

机构信息

Department of Life Science, Medical Research Institute, Kanazawa Medical University, 1-1 Daigaku-Uchinada, Kahoku-gun, Ishikawa, 920-0293, Japan.

Department of Respiratory Medicine, Kanazawa Medical University, 1-1 Daigaku-Uchinada, Kahoku-gun, Ishikawa, 920-0293, Japan.

出版信息

Cell Tissue Res. 2020 Sep;381(3):427-438. doi: 10.1007/s00441-020-03232-7. Epub 2020 Jun 15.

Abstract

Lung surfactant accumulates in the lamellar body (LB) via not only the secretory (anterograde) pathway but also the endocytic (retrograde) pathway. Our previous studies suggested that the major surfactant components, phosphatidylcholine and surfactant protein A take independent trafficking routes in alveolar type II cells. Thus, trafficking of surfactant protein B (SP-B), a major hydrophobic surfactant apoprotein, should be re-evaluated by a straightforward method. Radiolabeling of cells and subsequent cell fractionation were employed to pursue the sequential trafficking of newly synthesized SP-B in rabbit alveolar type II cells. The LB fraction was prepared by gradient ultracentrifugation. Immunoprecipitation from the culture medium, total cells, and LB fraction was carried out with anti-SP-B antibody. Newly synthesized [S]-pro-SP-B (~ 42 kDa) was detected in the cells after 1 h. An ~ 8-kDa mature form of [S]-SP-B was detected in the cells after 3 h and in the LB after 6 h. Mature [S]-SP-B was predominant in the cells after 24 h, and the dominant portion was present in the LB. In contrast, only a small amount of mature [S]-SP-B was present in the culture medium. Molecular processing of ~ 42 kDa [S]-pro-SP-B and transport to the LB was inhibited by brefeldin A, which disassembles the Golgi apparatus. These results suggest that newly synthesized SP-B is sorted to the LB via the Golgi and stored until exocytosis. This pathway is distinct from the pathways reported for phosphatidylcholine and surfactant protein A.

摘要

肺表面活性剂不仅通过分泌(顺行)途径,而且还通过内吞(逆行)途径在板层小体(LB)中积累。我们之前的研究表明,主要的表面活性剂成分,磷脂酰胆碱和表面活性蛋白 A 在肺泡 II 型细胞中采取独立的运输途径。因此,表面活性蛋白 B(SP-B)的主要疏水性表面活性剂辅蛋白的运输应该通过直接的方法进行重新评估。放射性标记细胞并用随后的细胞分级分离来研究新合成的 SP-B 在兔肺泡 II 型细胞中的连续运输。LB 级分通过梯度超速离心制备。用抗 SP-B 抗体从培养基、总细胞和 LB 级分中进行免疫沉淀。在 1 小时后,在细胞中检测到新合成的 [S]-pro-SP-B(42 kDa)。在 3 小时后在细胞中和在 6 小时后在 LB 中检测到成熟的 [S]-SP-B(8 kDa)。成熟的 [S]-SP-B 在 24 小时后在细胞中占优势,并且主要部分存在于 LB 中。相比之下,在培养基中仅存在少量成熟的 [S]-SP-B。Brefeldin A 抑制了 42 kDa [S]-pro-SP-B 的分子加工和向 LB 的转运,该蛋白会使高尔基体解体。这些结果表明,新合成的 SP-B 通过高尔基体分选到 LB 并储存,直到外排。该途径与磷脂酰胆碱和表面活性蛋白 A 的报道途径不同。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验